Anectine Injection, Solution
Product Images NDC 0781-9053

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Anectine (NDC 0781-9053). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Anectine Succinylcholine Chloride Chemical Structure (Anectine Nova 01)

Anectine Succinylcholine Chloride Chemical Structure (Anectine Nova 01)
Chemical structure of succinylcholine chloride illustrating the molecular arrangement with quaternary ammonium groups and chloride ions.*
FDA Label Image

Carton (Anectine Nova 02)

Carton (Anectine Nova 02)
Packaging label for Anectine (succinylcholine chloride injection, USP) 20 mg/mL solution. The label indicates the product is for intravenous use only and is supplied as 10 x 10 mL multiple-dose vials. The manufacturer listed is Sandoz Inc. The label prominently features a warning that Anectine is a paralyzing agent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.